F S&P 500
5,162.00 +7.25 (+0.14%) F Dow Jones
38,885.00 +53.00 (+0.14%) F Nasdaq
18,018.50 +17.75 (+0.10%) E-mini Russell 2000 Index Futur
2,056.20 +10.40 (+0.51%) Petróleo
78.73 +0.62 (+0.79%) Oro
2,321.60 +13.00 (+0.56%)
ZIVO Bioscience, Inc. (ZIVO)
ZIVO Bioscience, Inc.
21 East Long Lake Road
Suite 100
Bloomfield Hills, MI 48304
United States
(248) 452 9866
https://www.zivobioscience.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 8
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. John B. Payne | President, CEO & Chairman of the Board | 400k | N/D | 1948 |
| Mr. Keith R. Marchiando | CFO, Treasurer & Secretary | 312k | N/D | 1962 |
| Dr. Harlan L. Miller III | Vice President of Technology & Global Supply | N/D | N/D | N/D |
Descripción
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
Gestión corporativa
La calificación ISS Governance QuickScore de ZIVO Bioscience, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
